| Derivative Contracts |
5. Derivative Contracts The Company has derivative instruments that are used for hedging activities as discussed below. The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of June 30, 2026 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Notional Amounts of Derivative Instruments | | Notional Amount by Term to Maturity | | Classification by Notional Amount | | Under 12 months | | Over 12 months | | Total | | Cash Flow Hedge | | Non Hedge | | Total | | Forward contracts | $ | 1,030,684 | | | $ | 62,031 | | $ | 1,092,715 | | $ | 704,613 | | $ | 388,102 | | | $ | 1,092,715 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of June 30, 2025 (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Notional Amounts of Derivative Instruments | | Notional Amount by Term to Maturity | | Classification by Notional Amount | | Under 12 months | | Over 12 months | | Total | | Cash Flow Hedge | | Non Hedge | | Total | | Forward contracts | $ | 1,064,280 | | | $ | 79,858 | | $ | 1,144,138 | | $ | 765,613 | | $ | 378,525 | | | $ | 1,144,138 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
The fair value of the Company’s derivative instruments were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | As of June 30, | | | Balance Sheet Location | | 2026 | | 2025 | | Derivative assets | | | | | | | | Derivatives designated as hedging instruments: | | | | | | Foreign exchange forward contracts | | Prepaid expenses and other current assets | | $ | 17,110 | | | $ | 16,210 | | | Foreign exchange forward contracts | | Other non-current assets | | 156 | | | 3,715 | | | Derivatives not designated as hedging instruments: | | | | | | Foreign exchange forward contracts | | Prepaid expenses and other current assets | | 240 | | | 3,309 | | | Total derivative assets | | | | $ | 17,506 | | | $ | 23,234 | | | Derivative liabilities | | | | | | | | Derivatives designated as hedging instruments: | | | | | | Foreign exchange forward contracts | | Accrued expenses and other current liabilities | | $ | 10,085 | | | $ | 2,409 | | | Foreign exchange forward contracts | | Other non-current liabilities | | 988 | | | — | | | Derivatives not designated as hedging instruments: | | | | | | Foreign exchange forward contracts | | Accrued expenses and other current liabilities | | 5,932 | | | 36 | | | Total derivative liabilities | | | | $ | 17,005 | | | $ | 2,445 | |
The pre-tax effects of derivatives designated as cash flow hedging instruments on the consolidated financial statements were as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | Fiscal Year Ended June 30, | | 2026 | | 2025 | | 2024 | | | | | | | | Beginning balance of accumulated gains in accumulated other comprehensive loss | $ | 24,679 | | | $ | 41,424 | | | $ | 48,170 | | | Gross unrealized gains (losses) recognized in other comprehensive loss | 7,877 | | | (1,897) | | | 10,826 | | | | | | | | Net losses (gains) reclassified from cash flow hedge in accumulated other comprehensive loss into profit or loss: | | | | | | | Recognized in cost of revenues | 43 | | | 1,447 | | | 1,072 | | | Recognized in research and development | (12,840) | | | 7,194 | | | 7,718 | | | Recognized in marketing and sales | (3,223) | | | 1,027 | | | 1,264 | | | Recognized in general and administrative | (3,033) | | | 1,828 | | | 2,320 | | | Recognized in interest | (7,163) | | | (26,344) | | | (29,946) | | | Ending balance of accumulated gains in accumulated other comprehensive loss | $ | 6,340 | | | $ | 24,679 | | | $ | 41,424 | |
|